Evidence map›Paper›PMID 38158419›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2024

Recent updates in laryngeal hemangioma management: a scoping review.

Ali Almothahbi, Manal Bukhari, Mohammed Almohizea, Nawaf Alsubaie, Talal F Alharbi, Hassan M Alhazzani, Faisal Zagzoog

Abstract readScoping Review
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ali AlmothahbiKing Abdulaziz University Hospital, Riyadh, Kingdom of Saudi Arabia. dr-asas2008@hotmail.com.ORCID http://orcid.org/0009-0001-6517-6942
Manal BukhariKing Abdulaziz University Hospital, Riyadh, Kingdom of Saudi Arabia.
Mohammed AlmohizeaKing Abdulaziz University Hospital, Riyadh, Kingdom of Saudi Arabia.
Nawaf AlsubaieKing Abdulaziz University Hospital, Riyadh, Kingdom of Saudi Arabia.
Talal F AlharbiKing Abdulaziz University Hospital, Riyadh, Kingdom of Saudi Arabia.
Hassan M AlhazzaniKing Abdulaziz University Hospital, Riyadh, Kingdom of Saudi Arabia.
Faisal ZagzoogKing Abdulaziz University Hospital, Riyadh, Kingdom of Saudi Arabia.
King Abdulaziz University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo provide a comprehensive review of the current strategies in the management of laryngeal hemangiomas, with an aim to introduce a management algorithm that aligns with the variable clinical presentations and anatomical complexities of these lesions.

methodsWe conducted an extensive literature search across major databases using specific and general terms, combined with Boolean operators, to ensure comprehensiveness. Articles from January 2004 to August 2023 were included, with findings categorized by management approach.

resultsLaryngeal hemangiomas exhibit a spectrum of manifestations, ranging from asymptomatic lesions to those causing severe airway obstruction. Optimal management demands an individualized approach tailored to the patient's unique presentation and anatomical considerations. Diverse treatment modalities, each with distinct indications, advantages, and limitations, are explored. Notable highlights encompass the prominent role of Beta-blockers, notably Propranolol, in addressing problematic infantile hemangiomas, the nuanced efficacy of laser therapies contingent upon hemangioma type and depth, and the critical relevance of tracheotomy in emergencies. Novel approaches like transoral robotic surgery and transoral ultrasonic surgery, demonstrate promise in specific scenarios. We propose a management algorithm based on the complexity and presentation of laryngeal hemangiomas, emphasizing individualized treatment strategies, thereby addressing the unique challenges and nuances of each case.

conclusionLaryngeal hemangioma management requires personalized approaches informed by diverse therapies, clinical expertise, and collaboration. The review introduces an algorithm spanning observation to advanced interventions, adapting to each case's complexity. Ongoing research promises innovative treatments.

Indexed as

HemangiomaLaryngeal NeoplasmsAdrenergic beta-AntagonistsHumansPropranololTracheostomyTreatment OutcomeAdrenergic beta-AntagonistsPropranololLaryngeal hemangiomasLaser therapiesManagementManagement algorithmPropranolol

Identifiers

PMID38158419
OpenAlexW4390394164

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.